Acasti Pharma reported $64.89M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Acasti Pharma USD 64.89M 2.07M Dec/2025
Addus HomeCare USD 338.48M 8.94M Jun/2026
Amarin USD 51.48M 113K Dec/2025
Cassava Sciences USD 11.17M 2.38M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Option Care Health USD 1.36B 79.15M Jun/2026
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Tilray USD 237.52M 17.34M Sep/2025